HeyJaredDrug Diversion Insights with Terri Vidals
For everyone in the healthcare industry looking to reduce substance abuse and drug diversion. The host, Terri Vidals, is a pharmacist with over 30 years of experience; fifteen of those years in medication safety and drug diversion prevention and monitoring.
- Indexed episodes, last 90 days
- 12
- Latest publication
- Sep 23, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 8, 2026
Latest episodes
Inside a Pharmacist Recovery Network (opens the original)
Read excerpt
What happens when a pharmacist or pharmacy professional recognizes they need help with substance use disorder? Do they have to wait for an employer or licensing board to intervene—or can they seek support on their own terms? In this episode of Drug Diversion Insights , I’m joined by Brad Schwartz, Director of Pharmacy Services at Avita Health System and President of the board of the Pharmacists Rehabilitation Organization (PRO) , Ohio’s peer recovery network for pharmacy professionals. Brad take
Why Diversion Software Can't Do It Alone with Gordon Watkins, Wolters Kluwer (opens the original)
Read excerpt
Drug diversion software can help identify risk, analyze patterns, and prioritize potential concerns—but technology alone doesn't create an effective diversion prevention program . In this episode of Drug Diversion Insights , Gordon Watkins of Wolters Kluwer joins us to explore what actually makes a drug diversion program work and why people, process, and technology all need to be part of the strategy. Drug diversion often receives significant attention after a case is discovered. The harder chal
More Than a Substitute: The Truth About Buprenorphine (opens the original)
Read excerpt
Buprenorphine saves lives, yet it remains surrounded by myths, stigma, and misunderstanding. Is it simply replacing one opioid with another? What happens when a patient taking buprenorphine needs surgery or treatment for acute pain? And should a positive test for another substance mean treatment has failed? In this episode of Drug Diversion Insights , Jef Bratberg, PharmD, FAPhA, Clinical Professor of Pharmacy Practice at the University of Rhode Island , joins us for an evidence-based conversati
One Platform, Actionable Insight: A Comprehensive Approach to Diversion Management (opens the original)
Read excerpt
A strong drug diversion program shouldn't just help you investigate what already happened. It should help you identify risk earlier and give your team the information needed to act. In this episode of Drug Diversion Insights , Rick Couldry, Chief Pharmacy and Clinical Officer at Omnicell, and Jay Patel, Product Manager for Diversion Management , join us to explore how healthcare organizations can move from reactive diversion investigations toward a more proactive, connected approach to diversion
Should Healthcare Professionals Be Allowed to Use Cannabis? (opens the original)
Read excerpt
Cannabis laws are changing across the United States—but what should that mean for healthcare professionals working in safety-sensitive, patient-facing roles? In this episode of Drug Diversion Insights , Abby Migliore, COO of the Intervention Project for Nurses (IPN), and Shannon Opie, CEO , return to tackle one of the most complicated issues facing healthcare organizations today: cannabis, THC testing, workplace policy, impairment, and patient safety. Many healthcare facilities have strong drug
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about Drug Diversion Insights with Terri Vidals